Matches in Wikidata for { <http://www.wikidata.org/entity/Q66032260> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q66032260 description "clinical trial" @default.
- Q66032260 description "ensayu clínicu" @default.
- Q66032260 description "klinisch onderzoek" @default.
- Q66032260 description "клінічне випробування" @default.
- Q66032260 name "Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)" @default.
- Q66032260 name "Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)" @default.
- Q66032260 type Item @default.
- Q66032260 label "Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)" @default.
- Q66032260 label "Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)" @default.
- Q66032260 prefLabel "Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)" @default.
- Q66032260 prefLabel "Safety, Tolerability, and Immunogenicity of an Investigational Vaccine With Recombinant Human Albumin (rHA) in Children 12 to 18 Months of Age (V205C-009)(COMPLETED)" @default.
- Q66032260 P1050 Q66032260-C728AF28-B010-4D35-ACBB-D2BBF975CDF1 @default.
- Q66032260 P1132 Q66032260-C018DB16-043A-48CB-B8BE-3BEBC3636C1E @default.
- Q66032260 P1476 Q66032260-5E556BBF-7573-4C0A-A454-C40944518692 @default.
- Q66032260 P2899 Q66032260-64EE4857-81D4-49A7-A823-4105B1DE5EC4 @default.
- Q66032260 P3098 Q66032260-4A9B67EE-D485-4264-86F1-37741FBC1020 @default.
- Q66032260 P31 Q66032260-1CFC9702-52C6-451A-AD9D-ADDAD2B4F50F @default.
- Q66032260 P4135 Q66032260-F4ADF86F-9204-4B3E-B392-000170F8E749 @default.
- Q66032260 P580 Q66032260-A751AD94-7CC7-4379-823E-3DC7EC6635BD @default.
- Q66032260 P582 Q66032260-309C5ECD-00BF-4841-8346-98B62EF1271A @default.
- Q66032260 P6099 Q66032260-D1079A91-EF6B-4FF1-94A2-EDF5A33FC6FD @default.
- Q66032260 P8363 Q66032260-8A4EEE04-2CBC-4CE2-92B2-F17C77727108 @default.
- Q66032260 P1050 Q155857 @default.
- Q66032260 P1132 "+1210" @default.
- Q66032260 P1476 "A Comparison of the Safety, Tolerability, and Immunogenicity of V205C Manufactured With Recombinant Human Albumin (rHA) Versus V205C Manufactured With Pooled-Donor Human Serum Albumin (HSA) in Healthy Children 12 to 18 Months of Age" @default.
- Q66032260 P2899 "+12" @default.
- Q66032260 P3098 "NCT00092404" @default.
- Q66032260 P31 Q30612 @default.
- Q66032260 P4135 "+18" @default.
- Q66032260 P580 "2001-12-01T00:00:00Z" @default.
- Q66032260 P582 "2005-06-01T00:00:00Z" @default.
- Q66032260 P6099 Q42824440 @default.
- Q66032260 P8363 Q78089383 @default.